Japanese / English

The First International Conference 

2013年9月25.26開催 理研(公開)国際シンポジウム


主催:(独)理化学研究所 イノベーション推進センター 杉山特別研究室

日時:2013年9月25日(水) 12:45-17:50 (終了後、意見交換会18:15-20:30)

日時:2013年9月26日(木) 10:15-17:50

会場:日比谷図書館文化館 日比谷コンベンションホール(東京) Access


参加費:シンポジウム 無料 (先着200名様) 

参加費:意見交換会(日比谷聘珍樓) 6,000円



事前参加登録受付期間:2013年6月26日(水)~9月24日(火) AM 11:00


 [This meeting is a part of the RIKEN Symposium series.]


シンポジウム1: 日本人の演者は日本語で講演します。
シンポジウム2: 日本語のセッションです。
シンポジウム3: 英語のセッションです。


Academia Originated Drug Discovery and Development

25日(水) 12:45-17:50


Toshio Goto

RIKEN Program for Drug Discovery and Medical Technology Platform, Program Director

RIKEN Program for Drug Discovery and Medical Technology Platform


Yasuyoshi Watanabe

RIKEN Center for Life Science Technologies, Center Directer

PET Molecular Imαging for Drug Development


Michiaki Kubo

RIKEN Center for Integrative Medical Sciedces,Deputy Director

From Gene Discovery to Personalized Medicine


Yoshihide Hayashizaki

RIKEN Preventive Medicine & Diagnosis Innovation Program (PMI) , Program Director

The Exploration of Biomarkers and Preventive Medicine


Tetsuo Nagano

Open Innovation Center for Drug Discovery,The University of Tokyo, Professor

Difference between Academia and Industry in Drug Discovery



Hideo Utsumi

Phαrmαceuticals αnd Medicαl devices Agency,Executive Director, Director General of the Office of Review Innovation

The Science Board in PMDA


Jin-ding Huang

National Cheng Kung University,Professor,Taiwan

Building Trust and Cooperation among Academics,Industry,and Health Authorities


Kicking around Draft Guidance on Drug Interaction Studies

Supported by The Japanese Society for the Study of Xenobiotics (JSSX)

26日(木) 10:15-12:45


Yasuo Ohno

National lnstitute of Health Sciences,Visiting scientists

Revislon of Japanese Guidance on Drug Interaction Studies and its Basic Principle 


Hiroshi Suzuki

The University of Tokyo Hospital, Faculty of Medicine, the University of Tokyo, Professor

Major Points of the Revision of Japanese Guidance on Drug Interaction Studies 


Kiyomi Ito

Faculty of Pharmacy, Musashino University, Professor

Evaluation of Drug Interactions Involving Drug Metabolism 


Kazuya Maeda

Graduate school of Pharmaceutical Sciences, The University of Tokyo, Lecturer

Basic Concepts and Key Points of the Evaluation of Transporter-Mediated Drug Interactions 


Akihiro Hisaka

22nd Century Medical and Research Center, The University of Tokyo Hospital, Faculty of Medicine, The University of Tokyo, Associate Professor

Science Based Management of Drug Interactions 


Hot Topics of Pharmacokinetic Study in New Drug Discovery and Development 

Supported by Forum for Pharmaceutical Technology Innovation

26日(木) 14:00-17:50

Seiji Miyauchi

Faculty of Pharmaceutical Sciences, Laboratory of Pharmacokinetics Toho University, Professor

Na+-Dependent Opioid Peptide Transporter as a Molecular Target for Drug Development 


Hiroyuki Kusuhara

Graduate School of Pharmaceutical Sciences, The University of Tokyo, Professor

Quantitative Evaluation of the Impact of P-gp and Bcrp at the BBB on the Unbound Concentrations of Drugs in the Brain 


Ikumi Tamai 

Graduate School of Medical Sciences, Kanazawa University, Professor

Involvement of OATP2B1 in Drug Absorption and Interaction 

Ryota Kikuchi 

Abb Vie Inc. 

What, When, and Why of Drug Transporters: Strategies Across Discovery and Development 

Jasminder Sahi 

GSK Shanghai  

Discovery and Development of CNS Drug; Viewpoint from ADME Scientist 

【 問い合わせ先 】

杉山特別研究室 国際カンファレンス事務局

独立行政法人理化学研究所 イノベーション推進センター

〒230‐0045 横浜市鶴見区末広町1-6 横浜バイオ産業センター

TEL 045-506-1816    FAX  045-506-1800

E-mail : info [at] riken-sugiyama.jp   ※[at]は@に置き換えてください。